Community Pharmacists' Readiness for Breast Cancer Mammogram Promotion: A National Survey from Jordan
Lobna Gharaibeh,Mohammed Liswi,Reem Al-Ajlouni,Dina Shafei,Rasha Fakheraldeen
DOI: https://doi.org/10.2147/jmdh.s471151
2024-09-19
Journal of Multidisciplinary Healthcare
Abstract:Lobna Gharaibeh, 1 Mohammed Liswi, 2 Reem Al-Ajlouni, 3 Dina Shafei, 3 Rasha Ezzaldeen Fakheraldeen 3 1 Biopharmaceutics and Clinical Pharmacy Department, Al-Ahliyya Amman University, Amman, Jordan; 2 Civilian Research and Development Foundation (CRDF) Global, Amman, Jordan; 3 Jordan Breast Cancer Program, King Hussein Cancer Foundation, Amman, Jordan Correspondence: Lobna Gharaibeh, Biopharmaceutics and Clinical Pharmacy Department, Al-Ahliyya Amman University, Amman, Jordan, Tel +962796939977, Email Reem Al-Ajlouni, Jordan Breast Cancer Program, King Hussein Cancer Foundation, Amman, Jordan, Tel +962797070722, Email Purpose: Mammography is the gold standard screening technique for early detection of breast cancer. This study aimed to assess the knowledge of community pharmacists of different aspects emphasized by the JBCP programs. This study also identifies the attitudes and barriers towards promoting early detection services. Patients and Methods: This study was a cross-sectional survey of community pharmacists in Jordan. Pharmacists were randomly selected and asked to complete an electronic questionnaire. Inclusion criteria: a pharmacist with a bachelor's degree or higher and registered at the JPA working in a community pharmacy. The questionnaire included demographic and socioeconomic information, knowledge, attitudes towards breast cancer screening mammography services, and barriers towards participation in the promotion of these services. Results: A total of 1,088 community pharmacists were approached, 1,000 (91.8%) completed the questionnaire. Participants had an average age of 34 years ± 10.8 and average experience of 9.1 ± 9.5 years. Only 48 (37.8%) of the female pharmacists aged 40 years or older underwent a mammogram. Knowledge of symptoms of breast cancer was the highest with a score of 755, followed by knowledge of risk factors (670) and finally early detection of breast cancer (540). Many barriers were reported by the community pharmacists including lack of educational materials and time constraints. Pharmacists with higher educational levels (p< 0.001), of female gender (p< 0.001), attended continuous cancer-related education (p< 0.001), encountered a higher percentage of female customers (p< 0.001), in a certain geographic location (p=0.003), underwent mammography (p=0.014), and encountered high frequency of inquiries on mammogram by the customers (p< 0.001) were all associated with higher knowledge scores. Conclusion: Despite the reported barriers and insufficient knowledge in certain aspects of early detection of breast cancer, community pharmacists have positive attitudes and can be a valuable asset for awareness-raising efforts. Keywords: mammography, breast cancer, knowledge, attitude, barriers, Jordan breast cancer program, screening Breast cancer accounts for 20.6% of all cancer cases in both sexes, and 39.4% of all types of cancer in Jordanian women. 1 Similarly, international statistics show that breast cancer is the most commonly diagnosed cancer (2.26 million cases). 2 This percentage has increased by 69% over the last ten years. 1 Globally, the incidence was highest (112.3 per 100,000 population) in Belgium and lowest (35.8 per 100,000 population) in Iran. 3 The highest incidence of breast cancer in Asian and African countries occurred 10 years earlier than in western countries. 3 Age at breast cancer diagnosis exhibits different patterns among countries. The median age at diagnosis of breast cancer in the United States is 63 years, 4 50 years in China, 5 48.5 years in Arab countries, 6 and 51 years in Jordan. 1 These differences warrant tailored implementation of preventive and screening strategies among countries. Screening mammography plays a pivotal role in substantially reducing the risk of death from breast cancer, while maintaining a commendably low level of radiation exposure during the procedure. 7 Analysis of the 10-year follow-up data revealed that the fraction of detected small breast tumors increased from 36% to 68%, leading to a decline in the incidence of larger tumors from 64% to 32%. 8 Globally, improvements in breast cancer health outcomes, particularly decreased mortality rates, have been attributed to early detection. Five-year survival rates for breast cancer are lower in developing countries than in the United States. This is mainly attributed to the scarcity of early detection programs, inadequate diagnosis, and lack of treatment facilities. 9 The effect of screening mammography on the observed reduction in breast cancer mortality is variable and ranges fro -Abstract Truncated-
health care sciences & services